PMDA — authorised 19 December 2016
- Marketing authorisation holder: ASTELLAS PHARMA INC.
- Status: approved
PMDA authorised Linzess on 19 December 2016
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. PMDA authorised it on 19 December 2016.
ASTELLAS PHARMA INC. holds the Japanese marketing authorisation.